Target Pharmasolutions, Inc.
Clinical trials sponsored by Target Pharmasolutions, Inc., explained in plain language.
-
Massive study tracks fatty liver disease patients to uncover Real-World treatment patterns
Knowledge-focused CompletedThis study followed over 7,300 people with nonalcoholic fatty liver disease (NAFLD) and its more severe form, NASH, in regular doctor visits. Researchers aimed to understand how the disease progresses and what treatments doctors are using, since no drugs are officially approved f…
Sponsor: Target PharmaSolutions, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Long-Term PBC study reveals Real-World treatment patterns
Knowledge-focused CompletedThis study followed 711 adults with primary biliary cholangitis (PBC) for 5 years to see how the disease is managed in everyday medical practice. Researchers collected data on treatments, lab results, and side effects, and also stored blood samples for future genetic research. Th…
Sponsor: Target PharmaSolutions, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Scientists track COVID-19 in hospitalized patients to uncover key clues
Knowledge-focused CompletedThis completed study observed 199 adults hospitalized with confirmed COVID-19. Researchers tracked patient characteristics, treatments used, and how the disease progressed over time. The goal was to answer important questions about the natural history of COVID-19 to help guide fu…
Sponsor: Target PharmaSolutions, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC